DOI:
10.1055/s-00000089
Ultraschall in der Medizin
LinksClose Window
References
Gebel M, Caselitz M, Bowen-Davies PE, Weber S.
A multicenter, prospective, open label, randomized, controlled phase IIIb study of SH U 508 (Levovist®) for Doppler signal enhancement in the portal vascular system.
Ultraschall in Med 1998; 19: 48-156
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.